Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7370
Reference
MSAN(2021)25
Name
Clexane® (enoxaparin) pre-filled syringes
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. A shortage of the ERIS™ automatic safety system will impact the availability of several Clexane® prefilled syringes (listed below) from September until November 2021:
4000IU (40mg/0.4ml)
6000IU (60mg/0.6ml)
8000IU (80mg/0.8ml)
10,000IU (100mg/1ml)
2. All other Clexane® preparations are unaffected and remain available.
3. To mitigate the supply issue during this period, Sanofi will supply Clexane® with the PREVENTIS™ automatic safety system for the affected presentations only. This will be a UK licensed product.
4. Other brands of enoxaparin biosimilars remain available but cannot support an uplift in demand.
5. Organisations who use Clexane® should prepare to have syringes with two different safety devices in use across the portfolio and ensure appropriate communication and training of health care professionals and patients is undertaken before September.
Contact Name
Contact Email
Contact Address
Created
2021-08-03 00:00:00
Click to go back to homepage